Abstract:Vibrio anguillarum and Aeromonas hydrophila are the primary cause of mortality in marine and fresh water aquaculture.Mortality,due to disease from these two pathogens,has resulted in significant economic loss.Historically,infected fish have been treated with antibiotics,leading to widespread drug resistance among patho-genic bacteria.More recently,a number of vaccines against pathogenic bacteria have been developed and ap-proved for use in aquaculture.Although China has a long history of intensive fish culture,there has been little progress in developing/using vaccines for the treatment of fish diseases in this region.Our objective was to de-velop a combined,single application vaccine against V.anguillarum and A.hydrophila.We constructed a multi-valent vector vaccine(MVAV6203A-1) by fusing glyceraldehyde-3-phosphate dehydrogenase(GAPDH) from pathogenic A.hydrophila to attenuated V.anguillarum.We then evaluated the effectiveness of this vaccine against the two pathogens.Turbot,body length(8.99±0.73) cm,were immunized with the vaccine(MVAV6203A-1) by intraperitoneal injection(i.p.) or immersion.The fish were then challenged with virulent strain V.anguillarum MVM425 and A.hydrophila LSA34 by i.p injection and held for 30 d.We measured the relative percent survival(RPS) and antibody titers in the plasma against V.anguillarum by indirect ELISA at the end of the experiment.Fish that were given the vaccine by i.p.injection had high protections against MVM425 and LSA34 with RPS of 80.6% and 77.0% respectively.Similarly,the fish that were immersed in the vaccine also had a protection against MVM425(RPS 62.2%),but had a low protection against LSA34(RPS 11.7%).The plasma antibody titers were higher in the i.p.vaccination group(max: 2048,mean: 891) than in the control(mean: 97).Conversely,there was no difference in the mean antibody titer between the immersion treatment group and the control(mean: 64).Thus,our data suggest that the multivalent vector vaccine MVAV6203A-1 is effective in protecting turbot against bac-terial disease caused by Vibrio anguillarum and/or Aeromonas hydrophila. We discuss the limitations of evaluating vaccine efficiency using RPS and plasma antibody titers.The RPS and antibody titer were lower in the immersion immunization group than in the i.p.immunization group.However,this does not imply that immersion in the vaccine is associated with a weaker immune response in turbot.A num-ber of studies have shown that immersion challenge(not i.p.challenge) may be more suitable for evaluating the efficacy of vaccines that are delivered by immersion.This is because of differences in the antibody titer in the cutaneous mucus relative to the plasma.

Megalocytivirus-induced proteins of turbot (Scophthalmus maximus): identification and antiviral potential.

ORF75 of Megalocytivirus RBIV-C1: A Global Transcription Regulator and an Effective Vaccine Candidate.

Transcriptome Analysis Reveals Temperature-Regulated Antiviral Response in Turbot Scophthalmus Maximus.

Construction and Analysis of Experimental DNA Vaccines Against Megalocytivirus.

Global Profiling of Megalocytivirus-Induced Proteins in Tongue Sole (cynoglossus Semilaevis) Spleen Identifies Cellular Processes Essential to Viral Infection.

Identification and analysis of a CpG motif that protects turbot (Scophthalmus maximus) against bacterial challenge and enhances vaccine-induced specific immunity.

Immune response of turbot (Scophthalmus maximus L.) to a broad spectrum vaccine candidate, recombinant glyceraldehyde-3-phosphate dehydrogenase of Edwardsiella tarda.

P247 and P523: Two In Vivo-Expressed Megalocytivirus Proteins That Induce Protective Immunity and Are Essential to Viral Infection

Comparative Transcriptome Analysis Reveals the Immune Response of Turbot (scophthalmus Maximus) Induced by Inactivated Bivalent Vaccine.

Micro-transcriptome analysis reveals miRNA-mediated survival strategies between megalocytivirus RBIV-C1 and Scophthalmus maximus

Immune Responses and efficacy of an oral-emulsified bivalent vaccine against Vibrio anguillarum in turbot (Scophthalmus maximus)

Transcriptome Analysis of Turbot (scophthalmus Maximus) Head Kidney and Liver Reveals Immune Mechanism in Response to Vibrio Anguillarum Infection

Transcriptome analysis of turbot (Scophthalmus maximus) kidney responses to inactivated bivalent vaccine against Aeromonas salmonicida and Edwardsiella tarda

Transcriptome Analysis Reveals Immune-Related Genes in Tissues of Vibrio Anguillarum -Infected Turbot Scophthalmus Maximus

Evaluation of Immune Effects of a Multivalent Vector Vaccine in Turbot,scophthalmus Maximus

Identification of immune-related genes from kidney and spleen of turbot, Psetta maxima (L.), by suppression subtractive hybridization following challenge with Vibrio harveyi.

Outer membrane vesicles (OMVs) from Tenacibaculum maritimum as a potential vaccine against fish tenacibaculosis

Efficacy of Montanide™ ISA 763 A VG As Aquatic Adjuvant Administrated with an Inactivated Vibrio Harveyi Vaccine in Turbot (scophthalmus Maximus L.).

Molecular identification and expression analysis of four Lysin motif (LysM) domain-containing proteins from turbot (Scophthalmus maximus)

C7: A CpG Oligodeoxynucleotide That Induces Protective Immune Response Against Megalocytivirus in Japanese Flounder (paralichthys Olivaceus) Via Toll-Like Receptor 9-Mediated Signaling Pathway

The Efficacy and Side-Effects of Oil-Based Adjuvants Emulsified Vibrio Anguillarum Bivalent Inactivated Vaccine in Turbot (scophthalmus Maximus) under Production Mode